𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estimating vaccine costs for epi cost-effectiveness analysis

✍ Scribed by Rachel Feilden


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
298 KB
Volume
5
Category
Article
ISSN
0749-6753

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cost-effectiveness analysis of the Lyme
✍ Elizabeth C. Hsia; James B. Chung; J. Sanford Schwartz; Daniel A. Albert πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views
Cost-effectiveness analysis of hepatitis
✍ J. Barry O'Connor; Thomas F. Imperiale; Mendel E. Singer πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views

Our objective in this study was to determine the costeffectiveness of hepatitis A vaccination strategies in healthy adults in the United States. We constructed a decision model simulating costs and health consequences for otherwise healthy adults with respect to hepatitis A prevention. Three strateg

Advance market commitments for vaccines
✍ Ernst R. Berndt; Rachel Glennerster; Michael R. Kremer; Jean Lee; Ruth Levine; G πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 1 views

## Abstract The G8 is considering committing to purchase vaccines against diseases concentrated in low‐income countries (if and when desirable vaccines are developed) as a way to spur research and development on vaccines for these diseases. Under such an β€˜advance market commitment,’ one or more spo

Modelling for cost-effectiveness analysi
✍ Louise B. Russell πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 1 views

A model creates the framework for a cost-e!ectiveness analysis, allowing decision makers to explore the implications of using an intervention in di!erent ways and under di!erent conditions. To serve its purpose a model must produce accurate predictions and allow for substantial variation in the fact